Position in BMRN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,104,208
-$691,312 QoQ
Shares Held
36,774
-25.7% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#215
of 564 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $167,363,866 across 124 Biotechnology names. BMRN ranks #16 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,464 | $22,736,762 | |
| 2 | RPRX |
Royalty Pharma plc
|
337,298 | $18,912,298 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
35,471 | $17,619,509 | |
| 4 | EXEL |
Exelixis, Inc.
|
303,042 | $16,488,515 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
34,607 | $10,938,926 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
125,946 | $9,857,793 | |
| 7 | CELC |
Celcuity Inc.
|
71,445 | $7,474,575 | |
| 8 | INCY |
Incyte Corp
|
50,301 | $5,702,121 |
All Filings in BMRN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,104,208 | 36,774 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,795,520 | 49,487 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,319,374 | 39,027 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,570,487 | 47,461 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $2,165,927 | 39,402 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,596,533 | 22,585 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $940,399 | 14,307 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $766,161 | 10,900 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $669,342 | 8,130 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $511,113 | 5,852 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $706,469 | 7,327 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $675,102 | 7,630 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $492,082 | 5,677 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $464,904 | 4,781 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $347,829 | 3,361 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $264,991 | 3,126 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $257,228 | 3,104 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $252,425 | 3,274 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $330,075 | 3,736 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $268,428 | 3,473 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $307,226 | 3,682 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $255,374 | 3,382 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $290,166 | 3,309 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $283,778 | 3,730 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $529,991 | 4,297 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $380,588 | 4,504 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||